Promising phase 1 data presented by UCI Health radiologist at ASCO 2026
Nadine Abi-Jaoudeh, MD shared promising Phase 1 data at ASCO 2026 regarding a novel interventional approach for locally advanced pancreatic cancer.
Objective:
To present Phase 1 data on a novel interventional approach for locally advanced pancreatic cancer.
Approach:
- Study Design: The study targets patients with tumors encasing major vessels, making them unresectable despite induction chemotherapy.
- Intervention: Combines parallel photodynamic therapy with intravascular laser activation via a balloon catheter to destroy perivascular tumor tissue.
Key Findings:
- Successfully converted previously inoperable cases into candidates for Whipple procedures.
- Potentially increased five-year overall survival rates from 10-15% to 40-50%.
Interpretation:
Conclusion:
The study presents a significant advancement in the treatment of locally advanced pancreatic cancer.